
Joerg Herrmann MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor of Medicine
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Herrmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2010 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2006 - 2010
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
- Ruhr - University Bochum Faculty of MedicineClass of 1997
Certifications & Licensure
- IA State Medical License 2014 - 2025
- MN State Medical License 2005 - 2025
- WI State Medical License 2014 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure Start of enrollment: 2019 Aug 21
- Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial Start of enrollment: 2020 Sep 01
Publications & Presentations
PubMed
- 1 citationsThe year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology.Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon
European Heart Journal. 2025-04-01 - Comparison of the diagnostic and prognostic value of criteria for immune checkpoint inhibitor related myocarditis.Milagros Pereyra Pietri, Juan M Farina, Isabel G Scalia, Ahmed K Mahmoud, Michael Roarke
Cardio-Oncology. 2025-03-27 - Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease.Bernardo Casso-Chapa, Norma Alicia Vazquez González, Nhat-Tu Le, Nicolas L Palaskas, Kevin T Nead
Arteriosclerosis, Thrombosis, and Vascular Biology. 2025-03-01
Lectures
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
Press Mentions
- CV Admissions on the Rise in Americans with CancerAugust 9th, 2022
- In Neurodegenerative Diseases, Research Finds Shared Gene Patterns, Widespread DamageFebruary 2nd, 2022
- Time Tempers Anthracyclines into a Toxin or Treatment for CancerJanuary 31st, 2022
- Join now to see all
Grant Support
- TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) TrialMAYO CLINIC ROCHESTER2019–2025
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: